A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

NCT01632306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been terminated due to slow enrollment.

Conditions

Pancreatic Cancer

Interventions

DRUG: LY2090314
DRUG: FOLFOX
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

Eli Lilly and Company

Collaborators

[object Object]